Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA.
J Heart Lung Transplant. 2009 Dec;28(12):1306-11. doi: 10.1016/j.healun.2009.05.002. Epub 2009 Sep 26.
Physical functioning is without restriction in most pediatric heart transplant survivors, but only limited data are available about neuropsychologic outcomes in these children. In this study we assess neurodevelopmental outcomes in transplant survivors in comparison to population norms.
Neuropsychologic evaluations were performed 12 to 24 months (mean 16 months) post-transplant in 21 children ranging in age from 1 to 101 months (median 15 months) at time of transplant. Outcomes included verbal, non-verbal and overall intelligence; visual-motor integration skills; and adaptive functioning.
Transplant recipients had a mean overall IQ of 86.7, verbal IQ of 88.4 and non-verbal IQ of 87.5, all significantly below the normative population mean of 100 (p < 0.01). Thirty-eight to 43% of subjects had low IQ scores (i.e., <85), significantly more than the normative 16% base rate (p < 0.02). Children with an initial diagnosis of congenital heart disease (CHD) had lower overall IQ (mean 78.6) than those with cardiomyopathy (mean 91.7). The mean expressive language score was 88.1, significantly below norms (p < 0.01), with 46% having low scores (p = 0.01). Receptive language was normal in the same patients (mean 96.8). Finally, 63% of patients had visual-motor deficits and 48% had fine motor deficits (p < 0.005 compared with norms).
Although many pediatric heart transplant recipients display normal neurodevelopmental functioning, this population is at increased risk for cognitive difficulties, especially in expressive language, visual-motor integration and fine motor skills. Children with CHD may be at especially high risk. Early identification and intervention are essential to promote optimal neuropsychologic outcomes and overall quality of life in pediatric heart transplant recipients.
大多数儿科心脏移植幸存者的身体机能不受限制,但关于这些儿童的神经心理结果仅有有限的数据。在这项研究中,我们评估了移植幸存者的神经发育结果,并与人群正常值进行了比较。
在移植后 12 至 24 个月(平均 16 个月)对 21 名年龄在 1 至 101 个月(移植时中位数为 15 个月)的儿童进行了神经心理评估。结果包括言语、非言语和总体智力;视觉运动整合技能;以及适应功能。
移植受者的总智商平均值为 86.7,言语智商为 88.4,非言语智商为 87.5,均明显低于正常人群平均值 100(p < 0.01)。38%至 43%的受试者智商分数较低(即<85),明显高于正常的 16%基础率(p < 0.02)。先天性心脏病(CHD)初始诊断的儿童的总体智商(平均 78.6)低于心肌病(平均 91.7)。表达性语言的平均得分为 88.1,明显低于正常值(p < 0.01),其中 46%的得分较低(p = 0.01)。同一患者的接受性语言正常(平均 96.8)。最后,63%的患者存在视觉运动缺陷,48%的患者存在精细运动缺陷(与正常值相比,p < 0.005)。
尽管许多儿科心脏移植受者表现出正常的神经发育功能,但该人群认知困难的风险增加,尤其是在表达性语言、视觉运动整合和精细运动技能方面。患有 CHD 的儿童风险可能特别高。早期识别和干预对于促进儿科心脏移植受者的最佳神经心理结果和整体生活质量至关重要。